Description
<strong>Course Schedule - June 4-5, 2009</strong><br/><br/>This course will introduce the unique perspectives and
considerations of safety testing of biological drug products in
contrast to typical safety testing of chemically-derived
pharmaceuticals. Regulatory recommendations and
requirements at each level of development will be outlined
and accepted methods will be discussed in detail.<br><br>
The course will also use the history of the last 25 years of
safety assessment of biologically derived therapeutics and a
case study approach to identifying current approach
strengths, weaknesses and successful pathways.
01/13/2009
To
01/01/0001
Training Company
The Center for Professional Advancement (CfPA)
Industry
Biotech
Course Category
Brochure Name
http://www.cfpa.com/PDF/2009/2228,C8-221,0906-103.pdf
Address
New Brunswick, NJ USA